Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiodermatitis × Melatonin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Parasomnias 4 Neoplasms 4 Depression 3 Tuberous Sclerosis 2 Smith-Magenis Syndrome 2 Sleep Wake Disorders 2 Polycystic Ovary Syndrome 2 Pain 2 Fatigue 2 Autism Spectrum Disorder 2 Anxiety Disorders 2 Angelman Syndrome 2 Weight Loss 1 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Disorders, Circadian Rhythm 1 Relapsed Malignant Solid Tumor 1 Radiodermatitis 1 Radiation Injuries 1 Quality of Life 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Female Breast Cancer 1 Cardiovascular Diseases 1

Interventions

Low-Level Light Therapy 6 Standard of Care 4 Petrolatum 3 Norepinephrine 3 sapropterin 2 Curcumin 2 triethanolamine 1 eucerin 1 epigallocatechin gallate 1 dimethicone 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 calcipotriene 1 Zinc Oxide 1 Triamcinolone Acetonide 1 Thioctic Acid 1 Sodium Hypochlorite 1 Sodium Chloride 1 Silver Sulfadiazine 1 Radiotherapy, Conformal 1 Radiotherapy 1 Melatonin 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1 Gels 1 Dimethyl Sulfoxide 1 Catechin 1 Biafine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡